MEDIFAST INC (MED)

Data as of Oct 1, 2026, from SEC Form 4 filings.

Net insider buying (90d)Watch MED

See up to 3 months of MED. The 7-day demo opens the 1M and 3M ranges and puts MED on your watchlist.

Latest MED insider trades

Daniel R. Chard - Director
Open-market sale$114K
Sep 28, 2026
Daniel R. Chard - Director
Open-market sale$112K
Sep 29, 2026

About MEDIFAST INC (MED)

MEDIFAST INC files with the SEC under CIK 0000910329 and is classified as miscellaneous food preparations and kindred products. It is grouped with Consumer Staples companies on this site.

Sector: Consumer Staples

SEC filings for MED on EDGAR

MED Form 4 activity by transaction type, last 90 days

Form 4 transaction type	Transactions	Shares	Total value
Open-market purchase	8	119,966	$1.42M
Open-market sale	2	19,089	$226K

MED insider transactions (Form 4)

16 Form 4 filings on record, the earliest from Jun 13, 2025, newest first.

Date	Insider	Transaction	Security	Shares	Price	Value
Sep 28, 2026	Daniel R. Chard - Director	Open-market sale	Common Stock	9,545	$11.98^{footnote F1}	$114K
Sep 29, 2026	Daniel R. Chard - Director	Open-market sale	Common Stock	9,544	$11.73^{footnote F3}	$112K
Footnote F1 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $11.900 to $12.125, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR Footnote F3 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $11.670 to $11.810, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR
Aug 26, 2026	Parsa Kiai - Director	Open-market purchase	Common Stock	41,975	$12.26	$515K
Aug 26, 2026	Parsa Kiai - Director	Open-market purchase	Common Stock	1,175	$12.26	$14K
Aug 24, 2026	Parsa Kiai - Director	Open-market purchase	Common Stock	4,211	$12.00	$51K
Aug 24, 2026	Parsa Kiai - Director	Open-market purchase	Common Stock	118	$12.00	$1K
Aug 19, 2026	Parsa Kiai - Director	Open-market purchase	Common Stock	28,538	$11.66	$333K
Aug 19, 2026	Parsa Kiai - Director	Open-market purchase	Common Stock	799	$11.66	$9K
Aug 20, 2026	Parsa Kiai - Director	Open-market purchase	Common Stock	41,975	$11.60	$487K
Aug 20, 2026	Parsa Kiai - Director	Open-market purchase	Common Stock	1,175	$11.60	$14K
May 26, 2026	Jeffrey Matthew Rose - Director	Grant or award	Common Stock	11,680^{footnote F1}	$0.00	-
May 26, 2026	Jeffrey Matthew Rose - Director	Grant or award	Common Stock	6,739^{footnote F2}	$0.00	-
Footnote F1 (shares): These restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of… Full note on SEC EDGAR Footnote F2 (shares): The reporting person elected, pursuant to the Plan, to receive shares of the Issuer's common stock in lieu of cash compensation of annual service as a non-employee director of the Issuer.
May 26, 2026	Parsa Kiai - Director	Grant or award	Common Stock	11,680^{footnote F1}	$0.00	-
May 26, 2026	Parsa Kiai - Director	Grant or award	Common Stock	7,637^{footnote F2}	$0.00	-
Footnote F1 (shares): These restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of… Full note on SEC EDGAR Footnote F2 (shares): The reporting person elected, pursuant to the Plan, to receive shares of the Issuer's common stock in lieu of cash compensation of annual service as a non-employee director of the Issuer.
May 26, 2026	Andrea B. Thomas - Director	Grant or award	Common Stock	11,680^{footnote F1}	$0.00	-
Footnote F1 (shares): These restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of… Full note on SEC EDGAR
May 26, 2026	Scott Schlackman - Director	Grant or award	Common Stock	11,680^{footnote F1}	$0.00	-
Footnote F1 (shares): These restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of… Full note on SEC EDGAR
May 26, 2026	Elizabeth A. Geary - Director	Grant or award	Common Stock	11,680^{footnote F1}	$0.00	-
Footnote F1 (shares): These restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of… Full note on SEC EDGAR
May 26, 2026	Ming Xian - Director	Grant or award	Restricted Stock Units (cash settled)	11,680	$0.00	-
May 8, 2026	Scott Schlackman - Director	Open-market purchase	Common Stock	2,500	$12.65	$32K
May 11, 2026	Scott Schlackman - Director	Open-market purchase	Common Stock	2,500	$12.53	$31K
Mar 13, 2026	Jonathan Barrett Mackenzie - Officer	Tax withholding / forfeiture	Common Stock	198^{footnote F1}	$9.62^{footnote F1}	$2K
Mar 17, 2026	Jonathan Barrett Mackenzie - Officer	Tax withholding / forfeiture	Common Stock	70^{footnote F1}	$10.05^{footnote F1}	$704
Mar 25, 2026	Jonathan Barrett Mackenzie - Officer	Tax withholding / forfeiture	Common Stock	862^{footnote F1}	$9.59^{footnote F1}	$8K
Mar 25, 2026	Jonathan Barrett Mackenzie - Officer	Grant or award	Common Stock	10,830^{footnote F2}	$0.00	-
Footnote F1 (price, shares): Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share… Full note on SEC EDGAR Footnote F2 (shares): Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to… Full note on SEC EDGAR
Mar 13, 2026	James P. Maloney - Officer	Tax withholding / forfeiture	Common Stock	918^{footnote F1}	$9.62^{footnote F1}	$9K
Mar 17, 2026	James P. Maloney - Officer	Tax withholding / forfeiture	Common Stock	482^{footnote F1}	$10.05^{footnote F1}	$5K
Mar 25, 2026	James P. Maloney - Officer	Tax withholding / forfeiture	Common Stock	3,224^{footnote F1}	$9.59^{footnote F1}	$31K
Mar 25, 2026	James P. Maloney - Officer	Grant or award	Common Stock	34,344^{footnote F2}	$0.00	-
Mar 25, 2026	James P. Maloney - Officer	Grant or award	Common Stock	1,014^{footnote F3}	$0.00	-
Footnote F1 (price, shares): Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share… Full note on SEC EDGAR Footnote F2 (shares): Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to… Full note on SEC EDGAR Footnote F3 (shares): Represents shares of common stock issued upon the vesting and settlement of performance stock units previously granted to the reporting person on March 17, 2023, which were earned based on achievement of performance criteria certified by the Compensation Committee on February 5… Full note on SEC EDGAR
Mar 20, 2026	Daniel R. Chard - Officer	Open-market purchase	Common Stock	17,678	$10.11^{footnote F2}	$179K
Mar 25, 2026	Daniel R. Chard - Officer	Tax withholding / forfeiture	Common Stock	20,095^{footnote F1}	$9.59^{footnote F1}	$193K
Mar 25, 2026	Daniel R. Chard - Officer	Grant or award	Common Stock	36,968^{footnote F5}	$0.00	-
Mar 25, 2026	Daniel R. Chard - Officer	Grant or award	Common Stock	4,827^{footnote F6}	$0.00	-
Mar 13, 2026	Daniel R. Chard - Officer	Tax withholding / forfeiture	Common Stock	7,075^{footnote F1}	$9.62^{footnote F1}	$68K
Mar 17, 2026	Daniel R. Chard - Officer	Tax withholding / forfeiture	Common Stock	2,638^{footnote F1}	$10.05^{footnote F1}	$27K
Footnote F1 (price, shares): Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share… Full note on SEC EDGAR Footnote F2 (price): The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $10.04 to $10.18, inclusive. Footnote F5 (shares): Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to… Full note on SEC EDGAR Footnote F6 (shares): Represents shares of common stock issued upon the vesting and settlement of performance stock units previously granted to the reporting person on March 17, 2023, which were earned based on achievement of performance criteria certified by the Compensation Committee on February 5… Full note on SEC EDGAR
Jun 25, 2025	Jeffrey J. Brown - Director	Grant or award	Common Stock	11,168	$0.00	-
Jun 25, 2025	Jeffrey J. Brown - Director	Grant or award	Common Stock	9,449	$13.39	$127K
Jun 13, 2025	Daniel R. Chard - Officer	Open-market purchase	Common Stock	381	$13.13	$5K

Recent MED Form 8-K filings

Read MED company news

Aug 3, 2026Item 2.02, 9.01

Read the filing on SEC EDGAR

Jul 17, 2026Item 7.01, 9.01

Read the filing on SEC EDGAR

Jun 1, 2026Item 5.02, 9.01

Read the filing on SEC EDGAR

May 26, 2026Item 5.02, 5.07, 7.01, 9.01

Recent MED Form 144 notices of proposed sale

An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.

Filed	Filer	Relationship	Shares	Market value	Notice
Sep 29, 2026	Chard Daniel R	Officer	9,544	$112K	View on EDGAR
Sep 28, 2026	Chard Daniel R	Officer	9,545

MED insider trading FAQ

What is the latest insider trade for MED?

MEDIFAST INC (MED) had 4 insider filings in the last 90 days, with the most recent on 2026-10-01. The full record for MED runs to 16 Form 4 filings, the earliest from 2025-06-13. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.

How many insiders are buying MED stock?

8 insider purchases of MED were filed in the last 90 days, totaling $1.42M.

How many insiders are selling MED stock?

2 insider sales of MED were filed in the last 90 days, totaling $226K.

Where can I see MED SEC filings (Form 4, 10-K, 10-Q, 8-K)?

This page collects MED Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.

More Consumer Staples companies with insider activity

Recent insider filings

The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.

Oct 1, 2026 - Daniel R. Chard view on EDGAR
Aug 28, 2026 - Parsa Kiai view on EDGAR
Aug 26, 2026 - Parsa Kiai view on EDGAR
Aug 21, 2026 - Parsa Kiai view on EDGAR
May 28, 2026 - Jeffrey Matthew Rose view on EDGAR
May 28, 2026 - Parsa Kiai view on EDGAR
May 28, 2026 - Andrea B. Thomas view on EDGAR
May 28, 2026 - Scott Schlackman view on EDGAR
May 28, 2026 - Elizabeth A. Geary view on EDGAR

Related companies with recent insider activity

Learn more

How to read insider buying signals: What an open-market purchase by an insider can and cannot tell you.
Form 144 vs Form 4: A Form 144 announces a planned sale; the Form 4 reports it after it happens.
Insider activity in Consumer Staples: Where MED's peers are being bought and sold.
Every recent Form 4: The market-wide feed, updated as filings arrive from SEC EDGAR.

Follow MED with a 7-day demo

MED on your watchlist
Every MED Form 4 filing on record
Up to 3 months of MED price history
The daily trading plan of ranked insider buys, on a delay, with the plan archive

Start 7-day demoCard required. Your card is never charged for the demo.

Form 4 transaction type

Transactions

Total value

Open-market purchase

119,966

$1.42M

Open-market sale

19,089

$226K

Date

Insider

Transaction

Security

Price

Value

Sep 28, 2026

Daniel R. Chard - Director

Open-market sale

Common Stock

9,545

$11.98^{footnote F1}

$114K

Sep 29, 2026

Daniel R. Chard - Director

Open-market sale

Common Stock

9,544

$11.73^{footnote F3}

$112K

Footnote F1 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $11.900 to $12.125, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR
Footnote F3 (price): The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $11.670 to $11.810, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR

Aug 26, 2026

Parsa Kiai - Director

Open-market purchase

Common Stock

41,975

$12.26

$515K

Aug 26, 2026

Parsa Kiai - Director

Open-market purchase

Common Stock

1,175

$12.26

$14K

Aug 24, 2026

Parsa Kiai - Director

Open-market purchase

Common Stock

4,211

$12.00

$51K

Aug 24, 2026

Parsa Kiai - Director

Open-market purchase

Common Stock

118

$12.00

$1K

Aug 19, 2026

Parsa Kiai - Director

Open-market purchase

Common Stock

28,538

$11.66

$333K

Aug 19, 2026

Parsa Kiai - Director

Open-market purchase

Common Stock

799

$11.66

$9K

Aug 20, 2026

Parsa Kiai - Director

Open-market purchase

Common Stock

41,975

$11.60

$487K

Aug 20, 2026

Parsa Kiai - Director

Open-market purchase

Common Stock

1,175

$11.60

$14K

May 26, 2026

Jeffrey Matthew Rose - Director

Grant or award

Common Stock

11,680^{footnote F1}

$0.00

May 26, 2026

Jeffrey Matthew Rose - Director

Grant or award

Common Stock

6,739^{footnote F2}

$0.00

Footnote F1 (shares): These restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of… Full note on SEC EDGAR
Footnote F2 (shares): The reporting person elected, pursuant to the Plan, to receive shares of the Issuer's common stock in lieu of cash compensation of annual service as a non-employee director of the Issuer.

May 26, 2026

Parsa Kiai - Director

Grant or award

Common Stock

11,680^{footnote F1}

$0.00

May 26, 2026

Parsa Kiai - Director

Grant or award

Common Stock

7,637^{footnote F2}

$0.00

Footnote F1 (shares): These restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of… Full note on SEC EDGAR
Footnote F2 (shares): The reporting person elected, pursuant to the Plan, to receive shares of the Issuer's common stock in lieu of cash compensation of annual service as a non-employee director of the Issuer.

May 26, 2026

Andrea B. Thomas - Director

Grant or award

Common Stock

11,680^{footnote F1}

$0.00

Footnote F1 (shares): These restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of… Full note on SEC EDGAR

May 26, 2026

Scott Schlackman - Director

Grant or award

Common Stock

11,680^{footnote F1}

$0.00

Footnote F1 (shares): These restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of… Full note on SEC EDGAR

May 26, 2026

Elizabeth A. Geary - Director

Grant or award

Common Stock

11,680^{footnote F1}

$0.00

Footnote F1 (shares): These restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of… Full note on SEC EDGAR

May 26, 2026

Ming Xian - Director

Grant or award

Restricted Stock Units (cash settled)

11,680

$0.00

May 8, 2026

Scott Schlackman - Director

Open-market purchase

Common Stock

2,500

$12.65

$32K

May 11, 2026

Scott Schlackman - Director

Open-market purchase

Common Stock

2,500

$12.53

$31K

Mar 13, 2026

Jonathan Barrett Mackenzie - Officer

Tax withholding / forfeiture

Common Stock

198^{footnote F1}

$9.62^{footnote F1}

$2K

Mar 17, 2026

Jonathan Barrett Mackenzie - Officer

Tax withholding / forfeiture

Common Stock

70^{footnote F1}

$10.05^{footnote F1}

$704

Mar 25, 2026

Jonathan Barrett Mackenzie - Officer

Tax withholding / forfeiture

Common Stock

862^{footnote F1}

$9.59^{footnote F1}

$8K

Mar 25, 2026

Jonathan Barrett Mackenzie - Officer

Grant or award

Common Stock

10,830^{footnote F2}

$0.00

Footnote F1 (price, shares): Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share… Full note on SEC EDGAR
Footnote F2 (shares): Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to… Full note on SEC EDGAR

Mar 13, 2026

James P. Maloney - Officer

Tax withholding / forfeiture

Common Stock

918^{footnote F1}

$9.62^{footnote F1}

$9K

Mar 17, 2026

James P. Maloney - Officer

Tax withholding / forfeiture

Common Stock

482^{footnote F1}

$10.05^{footnote F1}

$5K

Mar 25, 2026

James P. Maloney - Officer

Tax withholding / forfeiture

Common Stock

3,224^{footnote F1}

$9.59^{footnote F1}

$31K

Mar 25, 2026

James P. Maloney - Officer

Grant or award

Common Stock

34,344^{footnote F2}

$0.00

Mar 25, 2026

James P. Maloney - Officer

Grant or award

Common Stock

1,014^{footnote F3}

$0.00

Footnote F1 (price, shares): Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share… Full note on SEC EDGAR
Footnote F2 (shares): Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to… Full note on SEC EDGAR
Footnote F3 (shares): Represents shares of common stock issued upon the vesting and settlement of performance stock units previously granted to the reporting person on March 17, 2023, which were earned based on achievement of performance criteria certified by the Compensation Committee on February 5… Full note on SEC EDGAR

Mar 20, 2026

Daniel R. Chard - Officer

Open-market purchase

Common Stock

17,678

$10.11^{footnote F2}

$179K

Mar 25, 2026

Daniel R. Chard - Officer

Tax withholding / forfeiture

Common Stock

20,095^{footnote F1}

$9.59^{footnote F1}

$193K

Mar 25, 2026

Daniel R. Chard - Officer

Grant or award

Common Stock

36,968^{footnote F5}

$0.00

Mar 25, 2026

Daniel R. Chard - Officer

Grant or award

Common Stock

4,827^{footnote F6}

$0.00

Mar 13, 2026

Daniel R. Chard - Officer

Tax withholding / forfeiture

Common Stock

7,075^{footnote F1}

$9.62^{footnote F1}

$68K

Mar 17, 2026

Daniel R. Chard - Officer

Tax withholding / forfeiture

Common Stock

2,638^{footnote F1}

$10.05^{footnote F1}

$27K

Footnote F1 (price, shares): Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share… Full note on SEC EDGAR
Footnote F2 (price): The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $10.04 to $10.18, inclusive.
Footnote F5 (shares): Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to… Full note on SEC EDGAR
Footnote F6 (shares): Represents shares of common stock issued upon the vesting and settlement of performance stock units previously granted to the reporting person on March 17, 2023, which were earned based on achievement of performance criteria certified by the Compensation Committee on February 5… Full note on SEC EDGAR

Jun 25, 2025

Jeffrey J. Brown - Director

Grant or award

Common Stock

11,168

$0.00

Jun 25, 2025

Jeffrey J. Brown - Director

Grant or award

Common Stock

9,449

$13.39

$127K

Jun 13, 2025

Daniel R. Chard - Officer

Open-market purchase

Common Stock

381

$13.13

$5K

Filed

Filer

Relationship

Market value

Notice

Sep 29, 2026

Chard Daniel R

Officer

9,544

$112K

View on EDGAR

Sep 28, 2026

Chard Daniel R

Officer

9,545